The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Tromethamine · TROMETHAMINE 3.6 g/100mL · Injection, Solution · Intravenous · Hospira, Inc.
NDC 00409-1593-04 · 6 BOTTLE, GLASS in 1 CASE / 500 mL in 1 BOTTLE, GLASS · NDA · View full market →
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| B. Braun Medical Inc. | TROMETHAMINE 3.6 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Hospira, Inc. | TROMETHAMINE 3.6 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Milla Pharmaceuticals Inc. | TROMETHAMINE 3.6 g/100mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Tham — NDC 00409-1593-04," retrieved September 3, 2026, https://drugdashboards.com/drug/00409159304.
Free to cite with attribution — see how the data is put together.